PIK3CA and colorectal carcinoma: Helmy MW et al. explored the effects of diosmin (DIO, a natural NF-κB inhibitor) and BEZ-235 (dactolisib, dual PI3K-mTOR inhibitor) in HCT-116 CRC cells [177].